Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
10.93
-0.01 (-0.09%)
At close: Dec 5, 2025, 4:00 PM EST
10.94
+0.01 (0.09%)
After-hours: Dec 5, 2025, 7:24 PM EST
Evoke Pharma Employees
Evoke Pharma had 3 employees as of December 31, 2024. The number of employees decreased by 1 or -25.00% compared to the previous year.
Employees
3
Change (1Y)
-1
Growth (1Y)
-25.00%
Revenue / Employee
$4,808,217
Profits / Employee
-$1,742,043
Market Cap
23.57M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EVOK News
- 11 days ago - Evoke assesses Italian unit sale amid tax concerns ahead of budget, Sky News reports - Reuters
- 4 weeks ago - MAI Capital Management Announces Expanded Office of Managing Partners Appointments Following Strategic Acquisition of Evoke Advisors - Business Wire
- 2 months ago - Evoke Advisors Ranked No. 1 on Forbes' ‘America's Top RIA Firms' List for Fourth Consecutive Year - Business Wire
- 3 months ago - MAI Capital Management Announces Strategic Partnership with Evoke Advisors - Business Wire
- 3 months ago - Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship - GlobeNewsWire
- 3 months ago - Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book - GlobeNewsWire
- 4 months ago - Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038 - GlobeNewsWire
- 5 months ago - Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036 - GlobeNewsWire